EMJ GOLD

Trump’s generic drug manufacturing tariff plan outlined future import duties and raised supply chain concerns. Read more.

It found that patients taking weight loss drugs had a modestly higher risk of developing non-scarring alopecia.

J&J receives FDA De Novo authorization for OTTAVA robotic surgical system, launching platform for soft tissue surgery in the US.

The company has reported sales growth of 3% in US dollar terms, as newer medicines offset patent losses.

Expanded AI infrastructure was introduced to strengthen artificial intelligence driven drug discovery, improve computational efficiency, and support the development of advanced research models across multiple therapeutic areas.

EMJ has been named a finalist in the Excellence in Health and Life Sciences category for its work with PARI Pharma GmbH.

Merck’s enlicitide has received FDA approval as the first oral PCSK9 inhibitor for lowering LDL-C in adults with hypercholesterolemia.

Lilly to buy AtaiBeckley for up to $3.8bn, gaining a psychedelic compound associated with Colorado River toad venom.